8BO7: Coagulation factor XI protease domain

Coagulation factor XI protease domain in complex with active site inhibitor 34. Determined by X-ray diffraction at 1.25 Å resolution. Released 13 Sept 2023.

Method
X-ray diffraction
Resolution
1.25 Å
Organism
Homo sapiens
Chains
1
Atoms
2,345
Mol. weight
27.71 kDa
Ligands
CIT, QW6
Released
13 Sept 2023

Explore 8BO7 in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

8BO7 contains 11 α-helices and 21 β-strands across 1 chain. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain AAA: 11 helices, 21 β-strands

ElementResiduesLengthSheet
β-strand38911
β-strand392-39322
β-strand402-40763
β-strand413-422103
β-strand425-42843
α-helix430-4334
α-helix439-4413
β-strand442-44543
β-strand45014
α-helix451-4533
β-strand461-46883
α-helix475-4773
β-strand482-48653
α-helix489-4924
β-strand49315
β-strand49615
β-strand50012
α-helix5011
α-helix5031
β-strand514-51852
β-strand53114
α-helix5321
β-strand533-53642
β-strand539-54022
α-helix542-5487
β-strand558-56142
β-strand56911
β-strand578-58362
β-strand586-595102
β-strand606-61052
α-helix611-6144
α-helix615-6228

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Coagulation factor XIa light chainAAAprotein238Homo sapiensP03951 (AlphaFold model)
Sequence of entity 1 (AAA), FASTA
>8BO7_1 Coagulation factor XIa light chain (chains AAA)
IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG
ILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDR
NVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGG
KDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV

Ligands and cofactors

IDNameFormulaCopies
CITCitric acidC6 H8 O71
QW64-[[(2~{S})-2-[4-(5-chloranyl-2-cyano-phenyl)-3-methoxy-6-oxidanylidene-2,5-dih…C28 H28 Cl N3 O61

Water and common crystallization additives (TRS) are not listed.

Primary citation

Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. Roehrig, S., Ackerstaff, J., Jimenez Nunez, E. et al. J Med Chem (2023) 66:12203-12224. DOI 10.1021/acs.jmedchem.3c00795 · PubMed

Other PDB entries of the same protein (UniProt P03951 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 8BO7 directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.